Correlation Between RYOHIN UNSPADR1 and CanSino Biologics

Can any of the company-specific risk be diversified away by investing in both RYOHIN UNSPADR1 and CanSino Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RYOHIN UNSPADR1 and CanSino Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between RYOHIN UNSPADR1 and CanSino Biologics, you can compare the effects of market volatilities on RYOHIN UNSPADR1 and CanSino Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RYOHIN UNSPADR1 with a short position of CanSino Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of RYOHIN UNSPADR1 and CanSino Biologics.

Diversification Opportunities for RYOHIN UNSPADR1 and CanSino Biologics

0.49

Correlation Coefficient

RYOHIN UNSPADR1  CanSino Biologics

Very weak diversification

The 3 months correlation between RYOHIN and CanSino is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding RYOHIN UNSPADR1 and CanSino Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CanSino Biologics and RYOHIN UNSPADR1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RYOHIN UNSPADR1 are associated (or correlated) with CanSino Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CanSino Biologics has no effect on the direction of RYOHIN UNSPADR1 i.e., RYOHIN UNSPADR1 and CanSino Biologics go up and down completely randomly.

Pair Corralation between RYOHIN UNSPADR1 and CanSino Biologics

Assuming the 90 days trading horizon RYOHIN UNSPADR1 is expected to generate 2.44 times less return on investment than CanSino Biologics. But when comparing it to its historical volatility, RYOHIN UNSPADR1 is 2.62 times less risky than CanSino Biologics. It trades about 0.2 of its potential returns per unit of risk. CanSino Biologics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  232.00  in CanSino Biologics on September 13, 2024 and sell it today you would earn a total of  170.00  from holding CanSino Biologics or generate 73.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

RYOHIN UNSPADR1  vs.  CanSino Biologics

RYOHIN UNSPADR1

Risk-Adjusted Performance

15 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in RYOHIN UNSPADR1 are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile forward-looking signals, RYOHIN UNSPADR1 reported solid returns over the last few months and may actually be approaching a breakup point.

CanSino Biologics

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in CanSino Biologics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CanSino Biologics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with RYOHIN UNSPADR1 and CanSino Biologics

The main advantage of trading using opposite RYOHIN UNSPADR1 and CanSino Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RYOHIN UNSPADR1 position performs unexpectedly, CanSino Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CanSino Biologics will offset losses from the drop in CanSino Biologics' long position.

The idea behind RYOHIN UNSPADR1 and CanSino Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.